Celiac Disease
252
34
40
148
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
19 trials with published results (8%)
Research Maturity
148 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.0%
15 terminated out of 252 trials
90.8%
+4.3% vs benchmark
3%
8 trials in Phase 3/4
13%
19 of 148 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 148 completed trials
Clinical Trials (252)
Enabling Microbiomics- Driven Personalized Nutrition
VTP-1000 in Adults With Celiac Disease
Gluten Technology and Education for Celiac Health
Coeliac Disease in Spain: Determination of Disease Prevalence and Risk Factors
Study of DONQ52 in Active Celiac Disease
Effects of Omega-3 Fatty Acids on Inflammation and Gut Microbiota in Celiac Disease
NCWS or IBS/FD in Relatives of CD Patients
Tissue Destruction and Healing in Celiac Disease
Efficacy of Cholesterol-lowering L. Plantarum on Cardiometabolic Health Biomarkers in Coeliac Disease Patients
Differences in Preparation for Small Bowel Capsule Endoscopy
Histomolecular Profiling in Small-Bowel Diseases
Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease
Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?
Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients
A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)
Gluten Challenge in Celiac Disease - Which Formulation of Gluten Gives the Best Response?
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study